sec filing
RN
NASDAQ · RNAZ
TransCode Therapeutics, Inc.
Healthcare · Biotechnology
$2.87
Down-$0.10 (-3.37%)
Updated Aug 24, 2026, 3:19 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.55M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $2.87 – $20.99
- Volume
- 42.18K
- Avg. volume
- 142.25K
Price performance
RNAZ price history
1M range · 20 trading sessions · Daily adjusted prices
RNAZ closed at $2.87 after 20 trading sessions, down 47.34% for the selected period.
- Last close
- $2.87
- Period change
- -47.34%
- Period low
- $2.87
- Period high
- $5.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $2.90 | $3.00 | $2.87 | $2.87 | 42.18K |
| Aug 20, 2026 | $3.121 | $3.28 | $2.87 | $2.97 | 45.69K |
| Aug 19, 2026 | $3.27 | $3.4899 | $3.03 | $3.21 | 76.13K |
| Aug 18, 2026 | $3.00 | $3.37 | $3.00 | $3.24 | 22.06K |
| Aug 17, 2026 | $3.36 | $3.4978 | $2.9432 | $3.16 | 81.26K |
| Aug 14, 2026 | $3.50 | $3.70 | $3.21 | $3.28 | 41.01K |
| Aug 13, 2026 | $3.42 | $3.50 | $3.30 | $3.48 | 23.98K |
| Aug 12, 2026 | $3.40 | $3.61 | $3.32 | $3.37 | 21.58K |
| Aug 11, 2026 | $3.90 | $3.9799 | $3.43 | $3.43 | 24.12K |
| Aug 10, 2026 | $3.91 | $4.26 | $3.88 | $3.88 | 20.14K |
| Aug 7, 2026 | $4.00 | $4.3099 | $3.96 | $3.96 | 28.59K |
| Aug 6, 2026 | $4.30 | $4.30 | $3.99 | $4.27 | 13.39K |
| Aug 5, 2026 | $4.54 | $4.54 | $4.25 | $4.25 | 8.37K |
| Aug 4, 2026 | $4.38 | $4.72 | $4.38 | $4.45 | 14.48K |
| Aug 3, 2026 | $4.5207 | $4.62 | $4.22 | $4.22 | 10.71K |
| Jul 31, 2026 | $5.13 | $5.3699 | $4.47 | $4.56 | 30.26K |
| Jul 30, 2026 | $5.06 | $5.505 | $5.0014 | $5.25 | 10.35K |
| Jul 29, 2026 | $4.85 | $5.3136 | $4.80 | $4.96 | 5.23K |
| Jul 28, 2026 | $5.80 | $6.00 | $4.5001 | $5.00 | 42.48K |
| Jul 27, 2026 | $5.89 | $6.125 | $5.40 | $5.45 | 24K |
Latest RNAZ news
The latest Smart Investors Daily articles mentioning RNAZ.
Stock researchCompany · Earnings
Loading stock research…

